Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.5K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.5K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.7K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

medRxiv : the preprint server for health sciences·2026
Same author

Liver-to-Atria Inflammatory Axis Driving Arrhythmia.

bioRxiv : the preprint server for biology·2026
Same author

EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan.

Cancer letters·2026
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut.

Cell·2026
Same author

An old foe comes swooping back: Whooping cough resurgence-Okay, now what?

PLoS pathogens·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Same journal

Dementia risk in middle-aged people linked to a blood protein.

Nature·2026
Same journal

Daily briefing: What's really happening with trust in science.

Nature·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 20, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

粘膜ワクチン接種は,クロストリディオイドス・ディフィフィシャル菌のコロニー化をクリアする.

Audrey K Thomas1,2, F Christopher Peritore-Galve1,2, Alyssa G Ehni1,2

  • 1Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Nature
|February 18, 2026
PubMed
まとめ
この要約は機械生成です。

粘膜ワクチン接種は,クロストリディオイドス・ディフィシル感染 (CDI) を効果的に除去し,腸内の特定の免疫反応を誘発することによって再発を予防します. このアプローチは,CDIに対する従来の親腸内ワクチン接種方法と比較して,より優れた保護を提供します.

さらに関連する動画

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.3K

関連する実験動画

Last Updated: Feb 20, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.3K

科学分野:

  • 微生物学 微生物学とは
  • 免疫学 免疫学とは
  • ワクチン学 ワクチン学

背景:

  • クロストリディオイドス・ディフィシル感染 (CDI) は,高頻度で病院内感染の主な原因である.
  • 以前の親腸内ワクチンでは,粘膜免疫を誘導しないため,病原体の伝播と再発を防ぐことができなかった.

研究 の 目的:

  • 新型C. difficileワクチンの粘膜投与と親腸投与の有効性を比較する.
  • ワクチン接種後の免疫関連性の保護と病原体クリアランスを特定する.

主な方法:

  • 活性化されていない毒素と表面抗原を添加した多価剤ワクチンは,直腸 (粘膜) または腹腔内 (親腸) で投与されました.
  • 保護,コロニー化負担,免疫反応 (便のIgG,大腸のT細胞) を評価した.

主要な成果:

  • 粘膜免疫は,親体免疫とは異なり,宿主からC. difficileを成功裏に除去しました.
  • 重要な相関項には,表面抗原に対する糞便のIgGと,胞子抗原に対するTヘルパー型17 (TH17) の反応が含まれていた.
  • 粘膜ワクチン接種は,CDIの罹病率,死亡率,組織損傷および再発に対して有意に保護されています.

結論:

  • 粘膜ワクチン接種は,CDIに対する不妊免疫を誘発し,親体経路よりも優れた有効性を示しています.
  • この研究は,C. difficileの感染と再発を防ぐために粘膜免疫の重要性を強調しています.